Influenza infection
Conditions
Interventions
Catechin-derivative-treated mask/60 days
Non-catechin-derivative-treated mask/60 days
Sponsors
University of Shizuoka
White Cross Nursing Home Osaka University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Written informed consent obtained before participation 2)Aged 20 years old or older 3)Opportunity to interact with influenza infected subjects 4)Willing and able to wear masks during the study period 5)Willing and able to fill out questionnaires
Exclusion criteria
Exclusion criteria: 1)Green tea allergy 2)Allergy to mask material 3)Severe immune disease 4)Chronic systemic infectious disease 5)History of influenza infection within the previous 6 months and influenza infection within 24 hours after participation 6)Subjects diagnosed by a physician inappropriate to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence rate of influenza-like illness during the study period | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)Incidence rate of laboratory-confirmed influenza A or B virus infection 2)Incidence rate of laboratory-confirmed influenza infection or influenza-like illness 3)Incidence rate of acute upper respiratory tract infection 4)Mask-wearing rate 5)Incidence of adverse device effect and defect | — |
Countries
Japan
Contacts
Public ContactHiroshi Yamada
University of Shizuoka School of Pharmaceutical Sciences
Outcome results
None listed